HIPEREMESIS GRAVIDARUM
Abstract
Abstrak. Hiperemesis gravidarum adalah muntah yang terjadi pada awal kehamilan sampai akhir kehamilan 20 minggu. Etiologinya belum diketahui secara pasti, tetapi beberapa ahli yang menyatakan bahwa erat hubungannya dengan faktor endokrin dan non endokrin. Mual dan muntah terjadi pada 60-80 % primigravida dan 40-60 % multigravida. 3, 4 Presentase hormon β-HCG akan meningkat sesuai dengan pertumbuhan plasenta. Diperkirakan hormon inilah yang mengakibatkan muntah melalui rangsangan terhadap otot polos lambung. Sehingga, semakin tinggi hormon HCG, semakin cepat pula rangsangan terhadap muntah mengakibatkan terhambatnya pertumbuhan janin. 4, 5, 6 Pada laporan kasus ini, kami memaparkan seorang wanita G1 Hamil 14-15 minggu datang dengan keluhan lemas akibat mual dan muntah sebanyak > 20 kali sehari sejak 1 hari sebelum masuk rumah sakit. Berdasarkan pemeriksaan fisik ditemukan mata cekung dengan turgor kembali < 2 detik. Hasil Laboratorium menunjukkan adanya hipoglikemia, dan ketonuria. Hasil ultrasonography (USG) ditemukan janin tunggal hidup intrauterin, usia kehamilan 11-12 minggu, CRL 4,63 cm. Berdasarkan PUQE (Pregnancy Unique Quantification of Emesis and Nausea) score, pasien didiagnosis dengan hiperemesis gravidarum stadium 1 dan mendapatkan terapi cairan, injeksi anti-emetik 4 mg/2 ml per 8 jam, asam folat 400 mcg per hari, dan suplementasi vitamin B kompleks per hari.
Kata Kunci : Hiperemesis gravidarum, ketonuria, PUQE score
Keywords
References
Daftar Pustaka
Jamal A, Pooransari P, Ansari R. Relationship between Helicobacter pylori seropositivity and hyperemesis gravidarum. Acta Medica Iranica Journal, Department of obstetrics and gynecology, Tehran university of medical sciences, Tehran, Iran. Vol. 42, No. 5, 2004, p 367-70.
Kazerooni T, Taallom M, Ghaderi A. Helicobacter pylori seropositivity among patients with hyperemesis gravidarum. Iran Journal Med Sci, Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran. Vol. 27, No. 2, 2002, p 67-9.
Kuscu N K, Koyuncu F. Hyperemesis gravidarum: Current concepts and management. Postgrad Med Journal, Department of Obstetrics and Gynaecology, Celal Bayar University, School of Medicine, Manisa, Turkey. Vol 78, 2002, p 76–9.
Verberg M F G, Gillott D J, Al-Fardan N, Grudzinskas J G. Hyperemesis Gravidarum, a literature review. Human Reproduction, Department of Obstetrics and Gynaecology, St. Bartholomew’s Hospital, West Smithfield, London. Vol. 10, 2005, p 1-13.
Aytac S, Turkay C, Kanbay M. Helicobacter Pylori Stool Antigen Assay in Hyperemesis Gravidarum: A Risk Factor for Hyperemesis Gravidarum or Not?. Dig Dis Sci, Department of Gastroenterology, Guven Hospital, Ankara, Turkey. Vol. 52, 2007, p 2840–43.
Lee R, Pan V, Wing D. The prevalence of Helicobacter pylori in the Hispanic population affected by hyperemesis gravidarum. American Journal of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Los Angeles County-University of Southern California Medical Center, Los Angeles. Vol. 193, 2005, p 1024-27.
American College of Obstetricians and Gynecologists:Practice Bulletin No. 153: nausea and vomiting of pregnancy. Obstet Gynecol 2015; 126:e12–e24.
Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V: Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev 2016; 5: 1–147.
Patterson AM: Hyperemesis Gravidarum.Ferri’s Clinical Advisor 2017; 6: 629i.
Lee NM, Saha S: Nausea and vomiting ofpregnancy. Gastroenterol Clin North Am2011; 40: 309–34.
Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk J J (Eds.) onbehalfof MBRRACE-UK (2014). ‘Saving Lives, Improving Mothers’ Care – Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiriesinto Maternal Deaths and Morbidity 2009–12’. Oxford: National Perinatal Epidemiology Unit, University of Oxford.
Institue of Obstetricians and Gynaecologists: Clinical Practice Guideline: Hyperemesis and Nausea/Vomiting in Pregnancy. Guideline No. 12. 2018: 1.0; e7-e8.
Spruill SC, Kuller JA: Hyperemesis gravidarum complicated by Wernicke’s encephalopathy. Obstet Gynecol 2002; 99(5 pt 2): 875–77.
Tan P, Norazilah MJ, Omar SZ: Dextrose saline compared with normal saline rehydration of hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol 2013; 121(2 pt 1): 291–98.
Longo L: Delayed-ReleaseDoxylamine-PyridoxineDrugMonograph. VA Pharmacy Benefits Management, 2015.
Pranowo KT, 2006. Analisis Biaya dan Keefektifitasan Ondansetron dan Deksametasone dalam Menekan Mual dan Muntah Pasca Bedah pada Bedah Rawat Jalan. Bag/SMF Anestesi dan Reanimasi Fakultas Kedokteran U.G.M. Tesis
American Society of Health – System Pharmacists, Metoclopramide Hydrochloride Drug Monograph. AHFS DI Essentials, 2017.
Pasternak B, Svanström H, Molgaard-Nielsen D, Melbye M, Hviid A: Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013; 310: 1601–11.
Simpson SW, Goodwin TM, Robins SB, Rizzo AA, Howes RA, Buckwalter DK, Buckwalter JG: Psychological factors and hyperemesis gravidarum. J Wones Health Gend Based Med 2001; 10: 471–77.
Maina A, Arrotta M, Cicogna L, Donvito V, Mischinelli M, Todros T, Rivolo S: Transdermalclonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI. BJOG 2014; 121: 1556–62.
Smith HS, Cox LR, Smith BR: Dopamine receptor antagonists. Ann Palliat Med 2012; 1: 137–42.
Omay O, Einarson A: Is mirtazapine an effective treatment for nausea and vomiting of pregnancy?: a caseseries. J Clin Psychopharmacol 2017; 37: 260–1.
Anttila S, Leinonen EV: A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001; 7: 249–64.
Bondok RS, El Sharnouby NM, Eid HE, Abd Elmaksoud AM: Pulsed steroid therapy is an effective treatment for intractable hyperemesis gravidarum. Crit Care Med 2006; 34: 2781– 83.
Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G: Birth defects after maternal exposure to corticosteroids: prospectivecohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.
Lindsey J. Wegrzyniak, DO, John T. Repke, MD, Serdar H. Ural, MD. Treatment of Hyperemesis Gravidarum. Obstet Gynecol. 2012; 5(2): 78-84.
Goodwin, T. M. (2008). Hyperemesis Gravidarum. Obstetrics and Gynecology Clinics of North America, 35(3), 401–17. doi: 10.1016/j.ogc.2008.04.002.
Cedergren M, Brynhildsen J, Josefsson A, et al. Hyperemesis gravidarum that requires hospitalization and the use of antiemetic drugs in relation to maternal body composition. Am J Obstet Gynecol 2008; 198: 412, e1–5.
Niebyl, J., & Nuangchamnong, N. (2014). Doxylaminesuccinate–pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: a review. International Journal of Women’s Health, 401. doi: 10.2147/ijwh.s46653.
Aleyasin, A., Saffarieh, E., Torkamandi, H., Hanafi, S., Sadeghi, F., Mahdavi, A.Javadi, M. (2015). Comparison of Efficacy of Ondansetron and Promethazine in Control of Hyperemesis Gravidarum. The Journal of Obstetrics and Gynecology of India, 66(6), 409–14. doi: 10.1007/s13224-015-0709-6.
Buchanan, M. L., Easterling, T. R., Carr, D. B., Shen, D. D., Risler, L. J., Nelson, W. L., Hebert, M. F. (2008). Clonidine Pharmacokinetics in Pregnancy. Drug Metabolism and Disposition, 37(4), 702–5. doi: 10.1124/dmd.108.024984.
Smit, M., Dolman, K. M., & Honig, A. (2016). Mirtazapine in pregnancy and lactation – A systematic review. European Neuropsycho pharmacology, 26(1), 126–35. doi: 10.1016/j.euroneuro.2015.06.014.
Kennedy, D. (2015). Ondansetron and pregnancy: Understanding the data. Obstetric Medicine, 9(1), 28–33. doi: 10.1177/1753495x15621154.
DOI: 10.24815/jks.v19i2.18065
Refbacks
- There are currently no refbacks.